Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Biomarkers in Medicine|February 3, 2012
Future potential biomarkers for postinterventional restenosis and accelerated atherosclerosisJacco C Karper, Mark M Ewing, J Wouter Jukema, et al.International Journal of Cardiology|May 13, 2023
EXpansion of stents after intravascular lithoTripsy versus conventional predilatation in CALCified coronary arteriesThomas Oomens, Nicola S Vos, René J van der Schaaf, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2010
Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in miceMark M Ewing, Margreet R de Vries, Mariette Nordzell, et al.Plos One|October 11, 2017
The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia developmentRob C M de Jong, Mark M Ewing, Margreet R de Vries, et al.Plos One|July 12, 2013
TLR accessory molecule RP105 (CD180) is involved in post-interventional vascular remodeling and soluble RP105 modulates neointima formationJacco C Karper, Mark M Ewing, Margreet R de Vries, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 26, 2012
Blocking toll-like receptors 7 and 9 reduces postinterventional remodeling via reduced macrophage activation, foam cell formation, and migrationJacco C Karper, Mark M Ewing, Kim L L Habets, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 22, 2013
Lysine acetyltransferase PCAF is a key regulator of arteriogenesisAntonius J N M Bastiaansen, Mark M Ewing, Hetty C de Boer, et al.Heart (British Cardiac Society)|November 11, 2010
Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studiesDouwe Pons, Stella Trompet, Anton J M de Craen, et al.Pageof 1